Takeda Eyes Brazil, China, Russia, Later Africa For Large Sales Growth
This article was originally published in PharmAsia News
Executive Summary
Takeda Pharmaceutical sees Brazil, China and Russia, three members of the BRICS emerging nations, as keys to its global strategy to increase total group sales by nearly half, to 20% in 2016.